Clinical Trial

Gait Analysis Parameter and Upper Limb Evaluation in Control Participants

Study acronym: ActiControl
Recruiting
View on ClinicalTrials.gov →
Summary
The ActiControl study is a monocentric, academic, and fully remote observational study designed to build a normative, longitudinal dataset using the Syde® wearable device. The study will enroll 200 healthy volunteers across all age groups, genders, and backgrounds. Participants will be remotely recruited and followed over two years, wearing the Syde® device for 3-week periods every 6 months. All study visits, including consent, data collection, and follow-up, are conducted remotely via phone or video conferencing. The primary objectives are to collect reference data on gait and movement patterns and to assess adherence and acceptability of the device. Secondary objectives include evaluating the reliability of digital endpoints and the influence of demographic and lifestyle factors on these measures.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-14; most recent amendment 2026-05-18.
Status change: Not Yet Recruiting → Recruiting 2025-12-01
Trial Details
NCT Number NCT07136506
Lead Sponsor Centre Hospitalier Universitaire de Liege
Collaborators: Centre Hospitalier Régional de la Citadelle, SYSNAV
Conditions Healthy Participants
Enrollment 200 participants
Start Date 2025-09-24
Primary Completion 2028-09 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-19